Significant Ownership of BeOne Medicines Ltd.

Signature - Title
BeiGene, Ltd. - Chan Lee Senior Vice President, General Counsel
Location
Basel
Summary
This page shows a list of all the recent SCHEDULE 13D/G filings made by BeOne Medicines Ltd..

Notify me when BeOne Medicines Ltd. files a new Schedule 13D/G report.

⭐ Subscribe ⭐

Significant Ownership of BeOne Medicines Ltd.

Sym Company Class Ownership Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
LPTX Leap Therapeutics, Inc. Common Stock, par value $0.001 per share 0% $474K 1.22M BeiGene, Ltd. 31 Oct 2024

Schedules 13D/G Reported by BeOne Medicines Ltd.:

Sym Target Class Ownership Change Current Shares Change Value Reporting name Form Report Period Filing Date
* An asterisk sign (*) next to the price indicates that the price is likely invalid.